Kidney Cancer Clinical Trials

Clinical Trial: VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clinical Trial: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Clinical Trial: MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

Clinical Trial: Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer (CMM)

Clinical Trials: Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

Clinical Trial: Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer

Clinical Trial: Autoantibody Blood Test in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Clinical Trial: Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer

Clinical Trial: Follow-Up Study of Kidney Cancer Patients

Clinical Trial: A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer

Clinical Trials: A Randomized Single Blind Controlled Trial of Beads vs. Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma (HCC)

Clinical Trials: Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor

Clinical Trials: Phase II Trial of High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma

Clinical Trials: Phase II Safety and Efficacy Study of Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Metastatic or Unresectable Sarcomatoid Renal Cell Carcinoma

Clinical Trials: Phase II Trial of Sunitinib Malate (Sutent) Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

For a complete listing of clinical trials pertaining to Kidney Cancer via ClinicalTrials.gov, click here.

Kidney Cancer News

How kidney cancer therapies could improve quality of life

Palliative care in endstage renal failure

Wilms' tumour: Assessing and managing nephroblastoma

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets

 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions